Autumn 1999 · Cambridge University, Department of Virology
The lecture hall emptied in the way of Tuesday afternoon sessions — gradually, with the particular noise of packed bags and resumed conversations, the academic decompression of students who had been required to be still and were now permitted to be otherwise. The lights were still at full overhead brightness, which gave the emptying room a slightly clinical quality, all the shadows pressed flat.
Alen was at his seat three rows from the front, organizing his notes with the systematic efficiency he applied to everything. His handwriting was very small and very even. His notes from a two-hour lecture occupied less space than most students' notes from thirty minutes, because he did not write what he could reconstruct — he wrote only the things that would not be obvious in retrospect, the gaps and the connections, the load-bearing ideas.
"Alen Richard."
He looked up.
She was standing at the foot of the lecture stairs with the quality of someone who had chosen a position rather than arrived at one. Late twenties, possibly thirty, with short dark hair and the posture of complete self-possession. Her lab coat was expensive in a way that announced itself — the fabric, the fit — which was an odd thing for lab wear and which suggested either that it was not actually worn in a lab or that she considered the lab an arena in which personal presentation mattered. She smelled, at this distance, of ozone and something expensive underneath it. Her eyes were doing what eyes rarely did to Alen: they were analyzing him with the specific focused quality of professional assessment, the gaze of someone identifying whether a specimen meets the criteria for further study.
He knew who she was. He had made it a habit to know who everyone in his extended professional orbit was, because information about people was the same as any other information — it was better to have it before you needed it.
"Dr. Radames," he said. He closed his notes. "You're the visiting researcher from the BioTerrorism Security Assessment Alliance. Your published work is on viral vector delivery optimization. Your unpublished work, according to the rumor architecture of this department, is considerably less theoretical."
Something moved in her expression — not surprise exactly, more the slight recalibration of an opening position.
"I read your paper on cellular regeneration," Carla said. She came up the stairs toward him, unhurried. "The one you published last spring. It was thorough. It was careful." She stopped two rows below him, which left her at eye level with him and was almost certainly calculated. "It was restrained. You stopped six conclusions short of where the data pointed."
"The data pointed toward forced mutation as a mechanism for acquired immunity," Alen said. "The lethality rate on that pathway runs above ninety percent across every analogous model. I am not interested in publishing a roadmap to killing nine people for every one you save."
"Progress is a ledger," Carla said. Her voice was smooth and precise and entirely free of apology. "The question is never whether there is a cost. The question is whether the outcome justifies the entry."
Alen slung his bag over his shoulder and began moving toward the aisle. She was offering him a debate, which was her method of holding him in place while she made her actual pitch. He recognized this because it was what he would have done.
"I am working on something," Carla said, not moving to block him but speaking with the calibrated precision of someone placing words exactly where they need to land. "Not a departmental project. Not anything that would appear in a university funding report. Something with genuine resources behind it — private backing, government-adjacent, the kind of infrastructure that doesn't need peer review because it has already moved past the stage where peer review is the relevant constraint." A pause. "A new approach to viral evolution. Not modification of existing pathogens. Directed genesis. Creating the pathogen from the desired outcome backward."
Alen stopped in the aisle.
He stood still for a moment. He was fifteen years old and he was doing the thing he had trained himself to do when a situation required honesty before response: checking what he actually felt, rather than what he had decided to feel. What he actually felt was a recognition of scale that was very difficult to dismiss. What she was describing — if it was real, if the resources were real — was not finger painting. It was the kind of problem that his mind moved toward the way a compass needle moves toward north, the deep-structure challenge that he had been aware, since childhood, that he was built for.
He was aware of this. He was aware also of what the awareness meant, and what he had to do with it.
"I know what you're building," he said. He kept his voice even, turned slightly so he could see her without giving her the full angle of his attention. "Not specifically. But the shape of it. Directed genesis with that funding profile and that security classification — the end application isn't medical. It isn't defense in any legitimate sense of that word. It's a weapon, Dr. Radames. The most significant one your backers believe they can construct."
"Weapons define eras," Carla said.
"They do," Alen agreed. "I have a newspaper on my shelf from 1998. I look at it occasionally. The city in the photograph was not a military target. The people in it were not combatants." He met her eyes. "I know what I'm built for, Dr. Radames. I know the size of the problems I can solve. I'm choosing not to solve that particular one."
Carla looked at him. The assessment was still running — he could see it — but something had shifted in its parameters.
"Your mother," she said, making the word sound like a diagnostic result, "has made you cautious."
"My mother," Alen said, walking, "taught me the difference between a question worth asking and a question worth stopping."
He left. His footsteps echoed off the empty lecture hall in the way of footsteps in a space built for an audience, and behind him, Carla Radames stood in the flat overhead light and watched the door close and thought about what she had just observed.
She reached into her coat pocket. The phone was a modified handset, encrypted at the hardware level, registered to a company that existed only on paper in a jurisdiction that asked few questions.
"He declined," she said, when the line connected. A pause while she listened. "I know. He's extraordinary — the processing speed, the analytical architecture, the way he reads three levels ahead in a conversation." Another pause. "There's something else. Something in his biology I can't place from observation alone. He has markers I've only seen in modified subjects, but he's not a subject. He's something else." She looked at the door. "Keep monitoring him. At a distance. Don't flag him — if he's what I think he might be, we don't want that particular interest drawn to him yet."
She ended the call. The lecture hall hummed with the particular silence of a room recently vacated, still holding the ghost-shape of the people who had been in it.
She put the phone away and picked up her briefcase and walked out into the autumn afternoon, already revising her model.
∗ ∗ ∗